Top Buy
Wertpapier | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Kurs | Kursziel | Potential |
---|---|---|---|---|---|---|---|
Select Medical Holdings | 6 | 0 | 2 | 0 | 30,60 € | 36,41 € | 18,98 % |
Alnylam Pharmace. | 36 | 0 | 1 | 0 | 141,20 € | 236,30 € | 67,35 % |
Ensign Group Inc. | 9 | 0 | 1 | 0 | 109,00 € | 116,99 € | 7,33 % |
Blueprint Medicines Corp | 2 | 0 | 1 | 0 | 101,05 € | - | - |
Exelixis Inc. | 18 | 0 | 1 | 0 | 20,07 € | 26,01 € | 29,58 % |
Myriad Genetics | 6 | 2 | 1 | 0 | 19,50 € | 24,18 € | 24,00 % |
Halozyme Therapeutics Inc. | 14 | 0 | 1 | 0 | 39,08 € | 50,33 € | 28,79 % |
Bio-Rad Labs Inc. A | 7 | 0 | 1 | 0 | 253,70 € | 445,58 € | 75,63 % |
Amedisys Inc. | 14 | 0 | 1 | 0 | 84,50 € | 92,26 € | 9,18 % |
Merit Medical Systems | 17 | 0 | 1 | 0 | 73,50 € | 86,90 € | 18,23 % |
Agios Pharmaceuticals Inc. | 6 | 0 | 1 | 0 | 31,00 € | 38,99 € | 25,77 % |
Ultragenyx Pharmaceutical Inc. | 17 | 1 | 1 | 0 | 38,80 € | 84,74 € | 118,41 % |
Chemed Corp. | 5 | 0 | 1 | 0 | 535,00 € | 588,14 € | 9,93 % |
CONMED Corp. | 12 | 1 | 1 | 0 | 66,00 € | 106,18 € | 60,88 % |
Catalent Inc. | 2 | 0 | 0 | 0 | 52,56 € | 55,00 € | 4,64 % |
Bruker Corp. | 7 | 1 | 0 | 0 | 68,62 € | 85,68 € | 24,87 % |
Repligen Corp. | 13 | 0 | 0 | 0 | 151,00 € | 184,76 € | 22,36 % |
Emergent Biosolutions Inc. | 2 | 3 | 0 | 0 | 4,07 € | 4,62 € | 13,47 % |
Molina Healthcare | 12 | 1 | 0 | 0 | 323,60 € | 366,73 € | 13,33 % |
Nektar Therapeutics | 3 | 1 | 0 | 0 | 1,54 € | 3,70 € | 140,89 % |
Insulet Corp. | 14 | 0 | 0 | 0 | 165,75 € | 215,54 € | 30,04 % |
Masimo Corp. | 7 | 1 | 0 | 0 | 117,75 € | 147,62 € | 25,36 % |
PTC Therapeutics Inc. | 14 | 5 | 0 | 0 | 28,40 € | 41,51 € | 46,17 % |
West Pharmaceutical Services Inc. | 6 | 0 | 0 | 0 | 336,80 € | 369,72 € | 9,78 % |
Medpace Holdings Inc | 9 | 0 | 0 | 0 | 366,00 € | 421,61 € | 15,19 % |